Abiopharma

KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine

Securities Fraud Investigation Into Acadia Healthcare Company, Inc. (ACHC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Enveric Biosciences to Present at and Participate in Panel Discussion During J.P. Morgan Week 2026

Biofrontera Notification (BFRI)

Edwards Lifesciences Corp - Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference

VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in Frances Real-World Evaluation of Early Detection of Sepsis

The Gross Law Firm Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - PRGO

Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium

DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your Rights - DXCM